VTRSViatris

Health care · Pharmaceuticals · Nasdaq

Viatris is a global healthcare company whose breadth and scale we believe make it uniquely positioned to address healthcare needs globally. 10-K, Item 1

Headquarters: Canonsburg, PA
CEO: Scott A. Smith
Next results: around Feb 25, 2027

Compare with peers → Embed

Deals between VTRS and its directors, executives, owners of more than 5% or their families: a relative on the payroll, a plane the company charters from its CEO, a director's company that buys from it. SEC rules (Item 404) make the company list every such deal over $120,000 in its proxy statement. Only one proxy is stored, so there is nothing to compare yet; the section is below.

The whole section 3 paragraphs, proxy filed 2026-04-02

Certain Relationships and Related Transactions

“Based on a review of any transactions between Viatris and its Directors, Director nominees and executive officers, their immediate family members, and their affiliated entities, Viatris has determined that since the beginning of 2025, it was or is to be a participant in the following transactions in which the amount involved exceeds $120,000 and in which any of Viatris’ Directors, executive officers, or greater than five percent shareholders, or any of their immediate family members, had or will have a direct or indirect material interest:”
Read it in the proxy ↗

Certain Relationships and Related Transactions

“Mr. Malik, a former Director and former executive officer of the Company, was party to an employment agreement with Mylan Inc., which contained standard indemnification provisions, and is currently party to a standard indemnification agreement with the Company. The Company has made payments to counsel to Mr. Malik of approximately $500,000 from January 1, 2025 through March 1, 2026 for services provided to Mr. Malik in connection with certain previously disclosed drug pricing matters. The Company anticipates making additional payments of approximately $650,000 in 2026 for ongoing services to be provided to Mr. Malik in connection with such matters. Viatris anticipates additional payment, repayment or advancement of these and other expenses during the pendency of these matters and anticipates that it will make payments for any such claims. In addition, in 2025, the Company made a payment to Mr. Malik equal to approximately $622,000, representing amounts relating to Company profit sharing contributions and his prior participation in the Company’s 401(k) Restoration Plan (the “Restoration Plan”). As previously disclosed, Mr. Malik served as an advisor to the Company on certain operational matters given his expertise in historical Company operations. In connection with his retirement from the Board, in November 2025, the Board approved a short-term extension to his advisory role to March 31, 2026 to further assist in these matters on current terms, which provided for continued vesting in equity awards that Mr. Malik held. The equity awards that Mr. Malik vested in as a result of the extended advisory period (261,490 PRSUs) were previously reported in prior Proxy Statements. The advisory period ended on March 31, 2026.”
Read it in the proxy ↗

Certain Relationships and Related Transactions

“Viatris has a written related party transactions policy that establishes guidelines for the Audit Committee to review and approve or ratify, as appropriate, transactions involving any Director, nominee for Director, “officer” (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), person known by the Company to be the beneficial owner of more than five percent of any class of the Company’s voting securities, or person known by the Company to be an immediate family member of any such person in which (1) the amount involved will or may be expected to exceed $100,000; (2) Viatris or an affiliate of Viatris is or will be a participant; and (3) any related party has or will have a direct or indirect material interest. The Board also annually reviews certain relationships and related party transactions as part of its assessment of each Director’s independence.”
Read it in the proxy ↗

Paragraphs are compared by their words, not read by AI: one counts as new when no paragraph last year shares half of its words, or when it names a person or company last year's section did not. A deal reported again with a new amount is not new. Always check the filing. Open the proxy ↗

Work on VTRS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/VTRS/export.csv") into a cell.